(Q84052223)
Statements
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study (English)
H Ralph Schumacher
Robert R Evans
Kenneth G Saag
James Clower
William Jennings
Steven P Weinstein
George D Yancopoulos
Jian Wang
Robert Terkeltaub